Search

Your search keyword '"Christen, Thomas"' showing total 154 results

Search Constraints

Start Over You searched for: Author "Christen, Thomas" Remove constraint Author: "Christen, Thomas" Database Unpaywall Remove constraint Database: Unpaywall
154 results on '"Christen, Thomas"'

Search Results

1. Racial and Ethnic Disparities in the Utilization and Outcomes with WATCHMAN FLX: A SURPASS analysis of the NCDR LAAO Registry

4. Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation

10. Two‐Year Outcomes With a Next‐Generation Left Atrial Appendage Device: Final Results of the PINNACLE FLX Trial

12. Transcatheter Aortic Valve Implantation with ACURATE neo: Results from the PROGRESS PVL Registry

14. Clinical Imaging of the Penumbra in Ischemic Stroke: From the Concept to the Era of Mechanical Thrombectomy

17. B-PO01-078 REAL-WORLD CLINICAL OUTCOMES WITH A NEXT-GENERATION LEFT ATRIAL APPENDAGE CLOSURE DEVICE: FIRST REPORT FROM THE FLXIBILITY POST-APPROVAL STUDY

23. Streamer Line Modeling

29. Multicomponent permanent magnets for enhanced electrical device efficiency

35. A FIRST-IN-HUMAN STUDY OF THE SECOND-GENERATION, THIN-STRUT, EVEROLIMUS-ELUTING BIORESORBABLE SCAFFOLD: 6-MONTH IVUS AND OCT RESULTS FROM THE FAST CLINICAL TRIAL

37. Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary intervention

40. TCT-583 Final 5-Year Results in Unselected Patients Implanted With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent: The PROMUS Element Plus US Post-Approval Study

42. Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

43. CLINICAL OUTCOMES TO 4 YEARS IN PATIENTS IMPLANTED WITH BIOABSORBABLE POLYMER SYNERGY VERSUS PERMANENT POLYMER EVEROLIMUS-ELUTING STENTS: THE EVOLVE II RANDOMIZED TRIAL

44. TCT-846 Clinical Outcomes in Patients Treated With the Fully Absorbable, Everolimus-Eluting RENUVIATM Scaffold: Primary Endpoint Results from the FAST First Human Use Study

45. TCT-729 Four-Year Clinical Outcomes in ‘Real-World’ Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent: Results from the PROMUS Element Plus US Post-Approval Study (PE-Plus PAS)

47. Use of endpoint adjudication to improve the quality and validity of endpoint assessment for medical device development and post marketing evaluation: Rationale and best practices. A report from the cardiac safety research consortium

Catalog

Books, media, physical & digital resources